1.17
0.00 (0.00%)
| Penutupan Terdahulu | 1.17 |
| Buka | 1.09 |
| Jumlah Dagangan | 238,707 |
| Purata Dagangan (3B) | 686,335 |
| Modal Pasaran | 58,285,184 |
| Harga / Jualan (P/S) | 0.800 |
| Harga / Buku (P/B) | 6.45 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 12 May 2025 - 16 May 2025 |
| Margin Keuntungan | -59.44% |
| Margin Operasi (TTM) | -79.73% |
| EPS Cair (TTM) | -0.960 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -9.30% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 1,107.91% |
| Nisbah Semasa (MRQ) | 0.610 |
| Aliran Tunai Operasi (OCF TTM) | -30.49 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -15.14 M |
| Pulangan Atas Aset (ROA TTM) | -17.49% |
| Pulangan Atas Ekuiti (ROE TTM) | -354.27% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Instruments & Supplies (US) | Bercampur | Bercampur |
| Medical Instruments & Supplies (Global) | Menaik | Bercampur | |
| Stok | Akoya BioSciences, Inc. | Bercampur | Bercampur |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | -3.5 |
| Osilator Teknikal | 0.0 |
| Purata | -1.57 |
|
Akoya Biosciences Inc is a life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery, clinical research and diagnostics. Its PhenoCycler® (formerly CODEX) and PhenoImager® (formerly Phenoptics) platforms, reagents, software, and services, It offer end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum from discovery through translational and clinical research and diagnostics. |
|
| Sektor | Healthcare |
| Industri | Medical Instruments & Supplies |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 72.58% |
| % Dimiliki oleh Institusi | 69.80% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Peddock Capital Advisors, Llc | 30 Sep 2024 | 234,720 |
| Osterweis Capital Management Inc | 30 Sep 2024 | 126,131 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |